Who is sponsoring NCT05256485?

NCT05256485 is sponsored by Sara Harby.

What condition does NCT05256485 study?

NCT05256485 studies Addiction Opiate.

Is NCT05256485 still recruiting?

NCT05256485 is currently completed. Last updated 25 February 2022.

Last reviewed 2022-02-25 · How we verify

NCT05256485

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison Between Different Psychotherapy Interventions Regarding Their Effect on Substance Craving

Completed NA Last updated 25 February 2022

What this trial tests

NA trial testing cognitive behavioral therapy,mindfulness based relapse prevention,twelve-step therapy in Addiction Opiate in 45 participants. Completed in 10 October 2021.

Timeline

15 October 2019

Primary endpoint
30 June 2021

10 October 2021

Quick facts

Lead sponsor	Sara Harby
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	45
Start date	15 October 2019
Primary completion	30 June 2021
Estimated completion	10 October 2021
Sites	1 location across Egypt

Drugs / interventions tested

cognitive behavioral therapy,mindfulness based relapse prevention,twelve-step therapy

Conditions studied

Addiction Opiate — all drugs for Addiction Opiate →

Sponsor

Sara Harby

Who can join

Adults 15 to 50, male only, with Addiction Opiate. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the study aim is to compare betwenn the effect of mindfulness based relapse prevention and other evidence based psychotherapy interventions regaring substance craving.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Addiction Opiate

Currently open trials in the same condition.

NCT05361603 — Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05256485 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sara Harby
Last refreshed: 25 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05256485.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing